Formulate
Jobs
Companies
Products
Indications
Toggle theme
Toggle theme
Menu
Home
Products
OBESTIN-30
OBESTIN-30
Post-LOE
phentermine hydrochloride
Ferndale Pharma Group
ANDA
ORAL
CAPSULE
Approved
Apr 1981
Lifecycle
Post-LOE
Competitive Pressure
30
/100
Overview
Company
FP
Ferndale Pharma Group
MI - Ferndale
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers